Belgium vs Türkiye: Cancer death rates by type
Belgium
2.34 deaths per 100,000 people
in 2021
Türkiye
2.37 deaths per 100,000 people
in 2023
Belgium rank
37th
Türkiye rank
36th
Cancer death rates by type over time
- Belgium
- Türkiye
How they compare
Türkiye currently reports 2.37 deaths per 100,000 people against 2.34 deaths per 100,000 people in Belgium, a difference of 0.03 deaths per 100,000 people.
The two have swapped places 3 times across 13 shared years of data; in 2009 it was Belgium ahead.
Belgium ranks 37th and Türkiye ranks 36th of 111 countries.
Belgium has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belgium | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.52 deaths per 100,000 people | 2.25 deaths per 100,000 people | 1.27 deaths per 100,000 people | Belgium |
| 2010s | 3.19 deaths per 100,000 people | 2.58 deaths per 100,000 people | 0.6014 deaths per 100,000 people | Belgium |
| 2020s | 2.43 deaths per 100,000 people | 2.43 deaths per 100,000 people | 0.0017 deaths per 100,000 people | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cancer death rates by type, Belgium or Türkiye?
- Türkiye, at 2.37 deaths per 100,000 people against 2.34 deaths per 100,000 people in Belgium as of 2023.
- What is the difference in cancer death rates by type between Belgium and Türkiye?
- 0.03 deaths per 100,000 people, with Türkiye ahead.
- How many years of comparable data are there for Belgium and Türkiye?
- 13 years are reported by both, from 2009 to 2021.
- How do Belgium and Türkiye rank globally for cancer death rates by type?
- Belgium ranks 37th and Türkiye ranks 36th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Cancer death rates by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from bladder cancer in both sexes in those aged all ages per 100,000 people.